Wird geladen...
Levetiracetam treatment ameliorates LRRK2 pathological mutant phenotype
Mutations in leucine‐rich repeat kinase 2 (LRRK2) are the most common genetic cause of Parkinson's disease (PD). The LRRK2 physiological and pathological function is still debated. However, different experimental evidence based on LRRK2 cellular localization and LRRK2 protein interactors sugges...
Gespeichert in:
| Veröffentlicht in: | J Cell Mol Med |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6850958/ https://ncbi.nlm.nih.gov/pubmed/31560168 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.14674 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|